Replies to post #386 on New York Health Care Inc (BBAL)

[$King]

Enterologics is buying BioBalance (BBAL), NYHC subsidiary

[$King]

"The sale of BioBalance will enable New York Health Care to concentrate on its core business," said Murry Englard, CEO of NYHC.

NYHC owns BioBalance (BBAL)

[$King]

CLARIFICATION

The Bio Balance transaction was not consummated until January 2003, in what became a reverse merger. Technically, although New York Health Care acquired Bio Balance, it was the start-up business that was the key player in the deal, as revealed by the company's new ticker symbol, BBAL.